MorphoSys Company
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Small&Large Molecules
Headquarters:
Planegg, Bayern, Germany
Founded Date:
1992-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
1
Total Funding:
1580000000
Estimated Revenue:
$50M to $100M
Last Funding Date:
2020-10-13
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership